6-32103061-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001365276.2(TNXB):​c.-8-4855A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0561 in 152,238 control chromosomes in the GnomAD database, including 343 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.056 ( 343 hom., cov: 32)

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.582

Publications

15 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
NM_001365276.2
MANE Select
c.-8-4855A>G
intron
N/ANP_001352205.1
TNXB
NM_001428335.1
c.-8-4855A>G
intron
N/ANP_001415264.1
TNXB
NM_019105.8
c.-8-4855A>G
intron
N/ANP_061978.6

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
ENST00000644971.2
MANE Select
c.-8-4855A>G
intron
N/AENSP00000496448.1
TNXB
ENST00000479795.1
TSL:1
c.-8-4855A>G
intron
N/AENSP00000418248.1
TNXB
ENST00000442721.1
TSL:1
c.-8-4855A>G
intron
N/AENSP00000389946.1

Frequencies

GnomAD3 genomes
AF:
0.0560
AC:
8525
AN:
152120
Hom.:
342
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0593
Gnomad ASJ
AF:
0.0257
Gnomad EAS
AF:
0.000960
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0436
Gnomad OTH
AF:
0.0584
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0561
AC:
8539
AN:
152238
Hom.:
343
Cov.:
32
AF XY:
0.0526
AC XY:
3916
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.105
AC:
4360
AN:
41512
American (AMR)
AF:
0.0593
AC:
906
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
89
AN:
3468
East Asian (EAS)
AF:
0.000963
AC:
5
AN:
5194
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4828
European-Finnish (FIN)
AF:
0.00283
AC:
30
AN:
10618
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0436
AC:
2968
AN:
68012
Other (OTH)
AF:
0.0578
AC:
122
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
426
851
1277
1702
2128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0444
Hom.:
735
Bravo
AF:
0.0644
Asia WGS
AF:
0.00982
AC:
34
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.9
DANN
Benign
0.29
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1269854; hg19: chr6-32070838; API